Document is current
Any future updates will be listed below
-
Authors
Counts, Nathaniel Z.
Gionfriddo, Paul
Chapman, Richard H.
- License Information
-
More Information
Article History
First Online: 18 March 2020
Compliance with Ethical Standards
:
: No funding was received for the completion of this work.
: Mr. Counts and Mr. Gionfriddo have no conflicts of interest to disclose. Dr. Chapman’s employer, the Institute for Clinical and Economic Review, has received grants from the California Health Care Foundation and the Laura and John Arnold Foundation. ICER as an organization has received membership dues, which are not related to this work, from a variety of payer and life science companies (Aetna, AHIP, Allergan, Alnylam, Anthem, Astra Zeneca, Biogen, Blue Shield of CA, Boehringer-Ingelheim, Cambia Health Services, CVS, Editas, Express Scripts, Genentech/Roche, GSK, Harvard Pilgrim, Health Care Service Corporation, Health Partners, HealthFirst, J&J (Janssen), Kaiser Permanente, LEO, Mallinckrodt, Merck, Novartis, NPC, Premera, Prime Therapeutics, Regeneron, Sanofi, Spark Therapeutics, and United Healthcare).
